TTC23 Antikörper (C-Term)
Kurzübersicht für TTC23 Antikörper (C-Term) (ABIN7185631)
Target
Alle TTC23 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- TTC23 Antibody
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human TTC23.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TTC23 (Tetratricopeptide Repeat Domain 23 (TTC23))
-
Andere Bezeichnung
- TTC23
-
Hintergrund
- Cervical cancer proto oncogene 8 protein antibody, Cervical cancer proto-oncogene 8 protein antibody, HCC 8 antibody, HCC-8 antibody, OTTHUMP00000190851 antibody, Protooncogene 8 antibody, Tetratricopeptide repeat domain 23 antibody, Tetratricopeptide repeat protein 23 antibody, TPR repeat protein 23 antibody, Ttc23 antibody, TTC23_HUMAN antibody
-
UniProt
- Q5W5X9
Target
-